Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Soho Global Health TbkISX:SOHO +0.42%87 FCF Yield % is 5.87 as of Sep. 06, 2026, which is 66% above its 10-year median of 3.53. GuruFocus rates ISX:SOHO with a GF Score™ of 87/100 and a GF Value™ of Rp805.04 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 121 Medical Distribution companies, PT Soho Global Health Tbk ranks better than 69.42% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
PT Soho Global Health Tbk FCF Yield % Related Terms
PT Soho Global Health Tbk FCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, PT Soho Global Health Tbk's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Soho Global Health Tbk FCF Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, PT Soho Global Health Tbk's FCF Yield % distribution charts can be found below:
* The bar in red indicates where PT Soho Global Health Tbk's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Soho Global Health Tbk (ISX:SOHO) has a FCF Yield % of 5.87 as of Sep. 06, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on PT Soho Global Health Tbk and its competitors. This is 66% above median its historical median of 3.53. According to the industry distribution chart, PT Soho Global Health Tbk ranks #37 out of 121 companies in the Medical Distribution industry, placing it in the top 30.6%.
Is PT Soho Global Health Tbk's FCF Yield % too high?
PT Soho Global Health Tbk's current FCF Yield % of 5.87 is 66% above median its 10-year median of 3.53. The Medical Distribution industry median FCF Yield % is 1.67. PT Soho Global Health Tbk's value of 5.87 is 251.5% above this industry median. Based on the distribution chart, PT Soho Global Health Tbk ranks #37 out of 121 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, PT Soho Global Health Tbk has a GF Score™ of 87/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PT Soho Global Health Tbk's FCF Yield % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, PT Soho Global Health Tbk ranks #37 out of 121 companies for FCF Yield %. This puts PT Soho Global Health Tbk in the upper half of its industry. The industry median FCF Yield % is 1.67. PT Soho Global Health Tbk's value of 5.87 is 251.5% above this benchmark. While the company's 10-year median is 3.53 vs. the industry median of 1.67, PT Soho Global Health Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Distribution company?
The median FCF Yield % among Medical Distribution companies is 1.67, based on 121 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Soho Global Health Tbk's current FCF Yield % of 5.87 is 251.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on PT Soho Global Health Tbk and its competitors. For the Medical Distribution industry, the median FCF Yield % is 1.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Soho Global Health Tbk's current FCF Yield % is 5.87, which is 66% above median its own 10-year median of 3.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Soho Global Health Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Soho Global Health Tbk (ISX:SOHO) is currently considered Significantly Overvalued. The stock's GF Value™ is Rp805.04, compared to a current price of Rp1,205.00 — trading 49.7% above its estimated fair value. The current FCF Yield % is 5.87, which is 66% above median its 10-year median of 3.53 and 251.5% above the Medical Distribution industry median of 1.67. PT Soho Global Health Tbk's overall GF Score™ is 87/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For PT Soho Global Health Tbk (ISX:SOHO), the current FCF Yield % is 5.87 as of Sep. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Soho Global Health Tbk (ISX:SOHO) Overvalued in 2026?
Based on GuruFocus' analysis, PT Soho Global Health Tbk stock appears to be overvalued.
The current stock price of Rp1,205.00 is trading 49.7% above its estimated GF Value™ of Rp805.04.
GuruFocus considers PT Soho Global Health Tbk to be Significantly Overvalued.
Key valuation signals for ISX:SOHO:
FCF Yield %: 5.87 (66% above median its 10-year median of 3.53)
GF Value™: Rp805.04 vs. price of Rp1,205.00 (49.7% above fair value)
Industry Position: 251.5% above the Medical Distribution median (#37 of 121)
No single metric tells the full story. See the ISX:SOHO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Soho Global Health Tbk is a healthcare company operating in the areas of natural/herbal health care products and services. The company manufactures and distributes pharmaceutical products, including herbal cures, proprietary medicines, and health foods, under various brand names such as Curcuma Plus, Curcuma Plus Milk; Imboost; Fitkom; Diapet; Laxing; Lelap; Asthma Soho, and Sohobion. Its segment includes Distribution, Consumer health, Alliance, and others. The company generates maximum revenue from the Distribution segment.
87GF Score
Get the complete analysis for ISX:SOHO
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:SOHO has been successfully added to your 
